Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06254521 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Effects of Neoadjuvant Tislelizumab Combined With Chemotherapy in Locally Advanced MSS Rectal Cancer

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 12, 2024 (before its estimated December 30, 2024 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This study aims to elucidate the effects of neoadjuvant Tislelizumab combined with chemotherapy in locally advanced MSS rectal cancer.
Trial Details
NCT Number NCT06254521
Lead Sponsor First Affiliated Hospital of Guangxi Medical University
Conditions
(from sponsor)		 Rectal Cancer, Rectal Cancer Stage II, Rectal Cancer Stage III
Related terms Rectal Neoplasms
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov